Compare, Analyse CORAL LAB. with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CORAL LAB. vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 CORAL LAB.   TEVA PHARMA
EQUITY SHARE DATA
    CORAL LAB.
Mar-21
TEVA PHARMA
Dec-13
CORAL LAB./
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs4433,141-   
Low Rs952,729-   
Sales per share (Unadj.) Rs270.51,802.6-  
Earnings per share (Unadj.) Rs38.0112.6-  
Cash flow per share (Unadj.) Rs43.5258.3-  
Dividends per share (Unadj.) Rs098.58-  
Avg Dividend yield %03.4 0.0%  
Book value per share (Unadj.) Rs382.82,002.4-  
Shares outstanding (eoy) m3.57848.00-   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.01.6 61.2%   
Avg P/E ratio x7.126.1 27.2%  
P/CF ratio (eoy) x6.211.4 54.5%  
Price / Book Value ratio x0.71.5 48.0%  
Dividend payout %087.5 0.0%   
Avg Mkt Cap Rs m9622,488,668 0.0%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m1020-   
Avg. sales/employee Rs ThNM34,011.1-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM2,124.6-  
INCOME DATA
Net Sales Rs m9661,528,629 0.1%  
Other income Rs m380-   
Total revenues Rs m1,0031,528,629 0.1%   
Gross profit Rs m161418,616 0.0%  
Depreciation Rs m20123,561 0.0%   
Interest Rs m330,025 0.0%   
Profit before tax Rs m176265,031 0.1%   
Minority Interest Rs m01,204 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-173,978 0.0%   
Tax Rs m41-3,236 -1.3%   
Profit after tax Rs m13695,492 0.1%  
Gross profit margin %16.727.4 60.9%  
Effective tax rate %23.0-1.2 -1,887.1%   
Net profit margin %14.06.2 224.7%  
BALANCE SHEET DATA
Current assets Rs m1,1081,032,430 0.1%   
Current liabilities Rs m278900,366 0.0%   
Net working cap to sales %86.08.6 995.6%  
Current ratio x4.01.1 347.9%  
Inventory Days Days13591 148.9%  
Debtors Days Days1,48096 1,543.2%  
Net fixed assets Rs m567499,284 0.1%   
Share capital Rs m363,763 0.9%   
"Free" reserves Rs m1,3310-   
Net worth Rs m1,3661,698,016 0.1%   
Long term debt Rs m0781,622 0.0%   
Total assets Rs m1,6753,493,406 0.0%  
Interest coverage x63.29.8 643.5%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.60.4 131.7%   
Return on assets %8.33.6 229.9%  
Return on equity %9.95.6 176.4%  
Return on capital %13.14.9 265.6%  
Exports to sales %72.30-   
Imports to sales %2.00-   
Net fx Rs m6680-   
CASH FLOW
From Operations Rs m11243,584 0.0%  
From Investments Rs m-2-86,312 0.0%  
From Financial Activity Rs m3-292,196 -0.0%  
Net Cashflow Rs m12-134,923 -0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 75.25 Rs / USD

Compare CORAL LAB. With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare CORAL LAB. With: BIOFIL CHEMICALS  WINDLAS BIOTECH  SHILPA MEDICARE  ALPA LAB  DENIS CHEM LAB  



Today's Market

Declining FMCG Sales, Shriram Properties IPO, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended on a weak note on Friday. Markets reversed their two-day winning streak with losses in index heavyweight Reliance Industries.

Related Views On News

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

More Views on News

Most Popular

Infosys vs TCS: Which is Better? (Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake (Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks (Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for (Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

5 Indian Companies Embracing Blockchain Technology (Views On News)

Nov 23, 2021

Blockchain adoption in India was slow in the past. Now, the technology is being well received.

More
-->

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2022
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: How to Profit from Sensex 100,000
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

CORAL LAB. SHARE PRICE


Dec 3, 2021 (Close)

TRACK CORAL LAB.

  • Track your investment in CORAL LAB. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CORAL LAB.

CORAL LAB. - ALEMBIC PHARMA COMPARISON

COMPARE CORAL LAB. WITH

MARKET STATS